135 related articles for article (PubMed ID: 16954805)
1. Matrix metalloproteinases as profibrotic factors in terminal ileum in Crohn's disease.
Warnaar N; Hofker HS; Maathuis MH; Niesing J; Bruggink AH; Dijkstra G; Ploeg RJ; Schuurs TA
Inflamm Bowel Dis; 2006 Sep; 12(9):863-9. PubMed ID: 16954805
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
McKaig BC; McWilliams D; Watson SA; Mahida YR
Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
[TBL] [Abstract][Full Text] [Related]
4. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
5. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.
Kirkegaard T; Hansen A; Bruun E; Brynskov J
Gut; 2004 May; 53(5):701-9. PubMed ID: 15082589
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease.
Meijer MJ; Mieremet-Ooms MA; Sier CF; van Hogezand RA; Lamers CB; Hommes DW; Verspaget HW
Inflamm Bowel Dis; 2009 Jan; 15(1):84-92. PubMed ID: 18634035
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis.
Shaida A; Kenyon G; Devalia J; Davies RJ; MacDonald TT; Pender SL
J Allergy Clin Immunol; 2001 Nov; 108(5):791-6. PubMed ID: 11692106
[TBL] [Abstract][Full Text] [Related]
9. Influence of cytokines on matrix metalloproteinases produced by fibroblasts cultured in monolayer and collagen gels.
Wong WR; Kossodo S; Kochevar IE
J Formos Med Assoc; 2001 Jun; 100(6):377-82. PubMed ID: 11480246
[TBL] [Abstract][Full Text] [Related]
10. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
11. [Effect of asiaticoside on the expression of transforming growth factor-beta mRNA and matrix metalloproteinases in hypertrophic scars].
Zhang T; Rong XZ; Yang RH; Li TZ; Xu YB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):67-70. PubMed ID: 16495179
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
13. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
14. Structural and molecular features of intestinal strictures in rats with Crohn's-like disease.
Talapka P; Berkó A; Nagy LI; Chandrakumar L; Bagyánszki M; Puskás LG; Fekete É; Bódi N
World J Gastroenterol; 2016 Jun; 22(22):5154-64. PubMed ID: 27298558
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory IL-1beta and/or TNF-alpha up-regulate matrix metalloproteases-1 and -3 mRNA in chondrocyte subpopulations potentially pathogenic in osteoarthritis: in situ hybridization studies on a single cell level.
Kunisch E; Kinne RW; Alsalameh RJ; Alsalameh S
Int J Rheum Dis; 2016 Jun; 19(6):557-66. PubMed ID: 25291965
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Rath T; Roderfeld M; Graf J; Wagner S; Vehr AK; Dietrich C; Geier A; Roeb E
Inflamm Bowel Dis; 2006 Nov; 12(11):1025-35. PubMed ID: 17075343
[TBL] [Abstract][Full Text] [Related]
17. Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: further evidence that proteolytically-active tryptase is a potent fibrogenic factor.
Zhang J; Gruber BL; Marchese MJ; Zucker S; Schwartz LB; Kew RR
J Cell Physiol; 1999 Nov; 181(2):312-8. PubMed ID: 10497310
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
Wilton E; Bland M; Thompson M; Jahangiri M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
[TBL] [Abstract][Full Text] [Related]
19. Contribution of intestinal smooth muscle to Crohn's disease fibrogenesis.
Severi C; Sferra R; Scirocco A; Vetuschi A; Pallotta N; Pronio A; Caronna R; Di Rocco G; Gaudio E; Corazziari E; Onori P
Eur J Histochem; 2014 Dec; 58(4):2457. PubMed ID: 25578979
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximab.
Di Sabatino A; Saarialho-Kere U; Buckley MG; Gordon JN; Biancheri P; Rovedatti L; Corazza GR; Macdonald TT; Pender SL
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1049-55. PubMed ID: 19357521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
